These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 5730284

  • 21. [Experience with the use of acrichine in patients in depressive states and catatonis(preliminary report)].
    Grudev FI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1565-71. PubMed ID: 6000321
    [No Abstract] [Full Text] [Related]

  • 22. [Practical problems in depressive states].
    Sutter JM.
    Mars Med; 1965; 102(5):455-9. PubMed ID: 5889118
    [No Abstract] [Full Text] [Related]

  • 23. Imipramine (Melipramine) therapy of depressions imitating internal diseases.
    Fejér A.
    Ther Hung; 1968; 16(2):69-71. PubMed ID: 5666416
    [No Abstract] [Full Text] [Related]

  • 24. [Response to psychotropic drugs in depressive syndromes. Clinico-statistical contribution].
    Bini A, Liberati F, Pompili A, Sinibaldi L.
    Riv Neurol; 1968 Dec; 39(6):605-14. PubMed ID: 5748175
    [No Abstract] [Full Text] [Related]

  • 25. [Burning mouth syndromes and depression. A psychoanalytic approach].
    Demange C, Husson C, Poï-Vet D, Escande JP.
    Rev Stomatol Chir Maxillofac; 1996 Dec; 97(4):244-52. PubMed ID: 8927932
    [Abstract] [Full Text] [Related]

  • 26. [Comparative study of the activity of sismotherapy and chemotherapy on the evolution of depressions by statistical methods].
    Gayral L, Raymondis LM, Schecktman Y, Privat C.
    Encephale; 1969 Dec; 58(1):5-18. PubMed ID: 5385378
    [No Abstract] [Full Text] [Related]

  • 27. [The depressive child (author's transl)].
    Nissen G.
    Monatsschr Kinderheilkd (1902); 1978 Aug; 126(8):463-71. PubMed ID: 355871
    [Abstract] [Full Text] [Related]

  • 28. [Use in general and psychosomatic medicine of 2 associations with mixed, anti-depressive and tranquilizing action (amitriptyline + perphenazine)].
    Ropert R.
    Therapeutique; 1970 May; 46(5):527-30. PubMed ID: 5430225
    [No Abstract] [Full Text] [Related]

  • 29. [Psychosomatic disorders considered from an internist viewpoint. II. Problems of drug therapy].
    Morini A, Pelliccia G, Mauceri P, Grandi M.
    Minerva Med; 1984 Aug 25; 75(32-33):1885-92. PubMed ID: 6148721
    [Abstract] [Full Text] [Related]

  • 30. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W, Stulz N, Köck K.
    J Affect Disord; 2009 Nov 25; 118(1-3):60-8. PubMed ID: 19217669
    [Abstract] [Full Text] [Related]

  • 31. Improving depression outcome: new concepts, strategies and technologies.
    Alpert JE.
    J Psychopharmacol; 2006 May 25; 20(3 Suppl):3-4. PubMed ID: 16644765
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment-refractory depression(chronic depression)].
    Okajima Y, Kato S.
    Ryoikibetsu Shokogun Shirizu; 2003 May 25; (38):271-4. PubMed ID: 12876981
    [No Abstract] [Full Text] [Related]

  • 33. [Advantages and dangers of a combined therapy with psychotropic drugs and psychotherapy].
    Langen D.
    Fortschr Med; 1979 Jun 21; 97(23):1088-90. PubMed ID: 37147
    [No Abstract] [Full Text] [Related]

  • 34. [The physician, the depressed patient and drug therapy].
    Cherpillod C.
    Rev Med Suisse Romande; 1971 Apr 21; 91(4):225-32. PubMed ID: 5563132
    [No Abstract] [Full Text] [Related]

  • 35. [Antidepressive pharmacological treatment of somatoform conditions and functional syndromes].
    Blach E, Fink PK.
    Ugeskr Laeger; 2005 Jan 10; 167(2):148-52. PubMed ID: 15697123
    [No Abstract] [Full Text] [Related]

  • 36. Pirroxan in the treatment of the neurovegetative component of the depressive syndrome.
    Gamkrelidze SA, Putkaradze-Gamkrelidze NA.
    Act Nerv Super (Praha); 1978 Feb 10; 20(1):67-8. PubMed ID: 205078
    [No Abstract] [Full Text] [Related]

  • 37. [Psychology aspects of otolaryngological disease, demonstrated by the example of headache].
    Schrappe O.
    HNO; 1973 Aug 10; 21(8):229-33. PubMed ID: 4733796
    [No Abstract] [Full Text] [Related]

  • 38. Antidepressants in the medically ill: prediction of benefits.
    Schwartz JA, Speed N, Beresford TP.
    Int J Psychiatry Med; 1989 Aug 10; 19(4):363-9. PubMed ID: 2630509
    [Abstract] [Full Text] [Related]

  • 39. [Antidepressants and somatic disease].
    Bryois C, Delacrausaz P, Didisheim S.
    Praxis (Bern 1994); 1999 Aug 19; 88(34):1351-6. PubMed ID: 10484882
    [Abstract] [Full Text] [Related]

  • 40. Depressive disorders.
    Butler R, Carney S, Cipriani A, Geddes J, Hatcher S, Price J, Von Korff M.
    Am Fam Physician; 2006 Jun 01; 73(11):1999-2004. PubMed ID: 16770932
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.